Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Shares Outstanding: 85.06M for April 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 29, 2024 | 85.06M |
April 03, 2024 | 84.86M |
March 31, 2024 | 84.86M |
March 15, 2024 | 84.69M |
March 11, 2024 | 84.69M |
December 31, 2023 | 79.70M |
October 27, 2023 | 72.41M |
September 30, 2023 | 69.15M |
July 28, 2023 | 69.00M |
June 30, 2023 | 68.99M |
June 14, 2023 | 68.87M |
May 15, 2023 | 67.98M |
May 02, 2023 | 63.85M |
April 18, 2023 | 63.20M |
March 31, 2023 | 63.20M |
March 06, 2023 | 63.20M |
February 17, 2023 | 62.72M |
February 16, 2023 | 62.45M |
December 31, 2022 | 44.81M |
October 28, 2022 | 44.76M |
September 30, 2022 | 44.76M |
July 29, 2022 | 43.39M |
June 30, 2022 | 43.38M |
Date | Value |
---|---|
April 29, 2022 | 43.34M |
April 18, 2022 | 43.34M |
April 01, 2022 | 43.33M |
March 31, 2022 | 43.33M |
March 07, 2022 | 43.33M |
December 31, 2021 | 43.07M |
November 02, 2021 | 43.07M |
September 30, 2021 | 43.07M |
August 03, 2021 | 43.02M |
July 01, 2021 | 42.93M |
June 30, 2021 | 42.62M |
May 03, 2021 | 42.46M |
April 09, 2021 | 42.45M |
April 01, 2021 | 42.45M |
March 31, 2021 | 41.85M |
March 15, 2021 | 41.85M |
December 31, 2020 | 41.73M |
November 03, 2020 | 41.73M |
September 30, 2020 | 41.70M |
August 04, 2020 | 41.66M |
June 30, 2020 | 41.66M |
June 26, 2020 | 41.66M |
June 22, 2020 | 41.66M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
41.66M
Minimum
Jun 22 2020
85.06M
Maximum
Apr 29 2024
54.29M
Average
43.36M
Median
Shares Outstanding Benchmarks
AstraZeneca PLC | 3.100B |
Landos Biopharma Inc (DELISTED) | 3.126M |
Acasti Pharma Inc | 9.399M |
Aurinia Pharmaceuticals Inc | 143.02M |
Edesa Biotech Inc | 3.216M |